A surprising resurgence of psychedelic research has produced its first FDA-approved treatment, with more likely on the way-- Read more on ScientificAmerican.com
(Cold Spring Harbor Laboratory Press) Written and edited by experts in the field, 'Next-Generation Sequencing in Medicine' from Cold Spring Harbor Laboratory Press examines next-generation sequencing technologies and their use, particularly...
(Burness) TB Alliance's new drug application (NDA) for the novel tuberculosis (TB) drug candidate pretomanid has been accepted for review by the United States Food and Drug Administration (FDA).